Back to Journals

International Journal of General Medicine

ISSN: 1178-7074

Dr Scott Fraser

Dr Fraser

Consultant Ophthalmologist, Sunderland Eye Infirmary, Sunderland, UK

Scott Fraser is a consultant ophthalmologist at Sunderland Eye Infirmary in the North East of the UK. He is also honorary lecturer at the University of Newcastle Upon Tyne and visiting professor at the University of Sunderland. He is a member of the Royal College of Surgeons of Edinburgh and the Royal College of Ophthalmologists.

He trained as an ophthalmologist initially in Newcastle and then completed his training at Moorfields Eye Hospital. At Moorfields he was also a research fellow initially looking into risk factors for late presentation of glaucoma and later as the Friend of Moorfields funded researcher looking at the genetics of glaucoma. He was awarded his MD in 2000.

His main clinical interest is in glaucoma in which he completed subspeciality training at Moorfields. His research interests also include glaucoma but more widely he is interested in factors that alter compliance with eye medications. He also has an interest in evidence based medicine and is an editor for the Cochrane Eyes and Vision group. He has published over 50 peer reviewed articles and over 100 presentations at scientific meetings. He has written chapters for 7 textbooks and has co-written a manual for eye care.

Dr Daniele Castellani

Section: Urology

Dr Castellani

Urology Division, University Hospital of Ancona United Hospitals, Polytechnic University, Ancona, Italy

Dr. Daniele Castellani is an attending physician in the Urology Department at the University Hospital Ospedali Riuniti di Ancona, Polytechnic University of Le Marche, Ancona, Italy. He is a member of the European Association of Urology. Dr. Castellani received his medical degree from the La Sapienza University in Rome, Italy. He was a medical resident in urology, at the University of L’Aquila, Italy. 

Dr. Castellani's research interests include benign prostatic hyperplasia, uro-oncology, lasers in urology, and urolithiasis. Dr. Castellani is member of the editorial board of several scientific journals. He has published 90 papers in index journals.

Professor Arthur E. Frankel

Section: Hematology

Professor Frankel

Chief of Hematology & Oncology, Department of Medicine, West Palm Beach VA Medical Center, West Palm Beach, FL, USA

Arthur E. Frankel, MD was born in Austin, Texas, attended Harvard College and Harvard Medical School and completed medical training at Yale University, the National Institutes of Health and Stanford University. He practiced and taught at Duke University, the Medical University of South Carolina, Wake Forest University, Texas A&M, the University of Texas Southwestern, and the University of South Alabama. He is now Chief Hematology and Oncology at the West Palm Beach VA Medical Center.

His clinical focus is malignant hematology, cutaneous malignancies and GU cancers. He has done research including the discovery of the first mammalian oncogenes, the generation of the first Her2 and PSA monoclonal antibodies, the finding of one of the first second site revertant enzyme mutations, discovery of a third lectin binding site on the plant toxin ricin, production of anti-leukemia fusion proteins, and reporting the first gut microbes critical for melanoma immunotherapy response. His interleukin 3-directed fusion protein was approved by the FDA in 2018 for a rare type of leukemia. His current goal is to provide outstanding and cutting edge clinical care to veterans.

Professor Mihajlo Jakovljevic

Section: Public Health

Professor Jakovljevic

Institute of Comparative Economic Studies, Hosei University, Tama Campus, Tokyo, Japan

Professor Mihajlo (Michael) Jakovljevic M.D. Ph.D. MAE published аpprox. 300 papers in indexed, peer reviewed journals (Hirsch Factor 62; Citations Count ͌ 66,800+; Cumulative Impact Factor app. 2000+; i-10 index 165). Being a professional health economist and clinical pharmacology physician, his expertise focuses on Emerging Markets and sustainability of health financing across LMICs countries worldwide. In Editor-in-Chief capacity he leads prestigious Cost Effectiveness and Resource Allocation, BMC journal since 2019 (IF=2.532) and was Founding Specialty Editor-in-Chief of Frontiers in Health Economics, based in Lausanne, Switzerland in 2016-2021 mandate (IF=3.709).
He is Professor and Founding Head of The Global Health, Economics and Policy Department at The University of Kragujevac situated in the historical capital of Serbia. He holds a JSPS funded Visiting Professorship at the Institute of Comparative Economic Studies, Hosei University Tokyo Japan. He is also an Expert affiliate of the CHTF IHME University of Washington since 2016 and used to hold a FORTE-funded Visiting Research Fellow position at Lund University, Sweden in the Division of Health Economics in 2018.
For his achievements and professional standing, in 2015 he became the first-ever nominated candidate from Eastern Europe for IHEA (International Health Economics Association) Board of Directors Elections. Over the past twenty years he has delivered plenary lectures and solicited speeches in well over thirty countries across Eurasia. During the past decade he continues to serve as Scientific Committee Member in top tier health economics and demography events such as IHEA, EuHEA, World Sustainability Forum. Since 2018 he continues as a WHO EACHR Committee member in an advisory capacity to the Cabinet of WHO Regional Director for Europe, based in Copenhagen, Denmark. In November 2021 he became first-ever Elected Ordinary Academician coming from Serbia, at the UNESCO World Academy of Sciences TWAS with its headquarters in Trieste, Italy. In June 2022 he was elected to Full Membership within Academia Europea, London, UK.

Dr Vinay Kumar

Section: Cardiology AND General Medicine

Dr Kumar

Heart and Vascular Institute, Pennsylvania State University, Hershey Medical Center, Hershey, PA, USA

Dr. Vinay Kumar holds a master's degree in biotechnology from Himachal Pradesh University, Shimla, India, as well as a PhD in Molecular Biology and Genetic Engineering from Jawaharlal Nehru University, New Delhi, India. Presently at Pennsylvania State University, he conducts thorough studies of dysregulated innate and adaptive immunological networks and their function in modulating the pathophysiology of myocardial infarction (MI) and chronic heart failure (HF).

Dr. Kumar is especially interested in determining the function of T-cell subsets and the time-dependent phenotypic changes that these cells endure during chronic HF. In addition, he is interested in identifying and devising novel strategies to reverse pathological changes in immune cells in preparation for their transition from the laboratory to the clinic. His training in physiology, immunology, and molecular biology equips him with unique perspectives to research heart failure and develop mechanism-based, clinically applicable immune-therapeutic strategies.

Dr Woon-Man Kung

Section: Clinical Neurology AND General Medicine

Dr Kung

Division of Neurosurgery, Department of Surgery, Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, New Taipei City, Taiwan

Woon-Man Kung received his M.D. degree from the School of Medicine, Taipei Medical University (TMU), Taipei, Taiwan in 1999. In 2012, he received his M.Sc. degree in Biomedical Engineering from the College of Medicine and College of Engineering, National Taiwan University (NTU), Taipei, Taiwan. Dr. Kung now serves as a Consultant Neurosurgeon in the Division of Neurosurgery, Department of Surgery, Taipei Tzu Chi Hospital (TCH), Buddhist Tzu Chi Medical Foundation, New Taipei City, Taiwan, as well as an Adjunct Associate Professor in the Department of Exercise and Health Promotion, College of Kinesiology and Health, Chinese Culture University (CCU), Taipei, Taiwan. He further participates as an International Membership of the professional association at the Congress of Neurological Surgeons (CNS), USA. He currently works in the Editorial/Advisory Board of several indexed journals and involves acting as an ad-hoc reviewer for a number of prestigious scientific journals.

Professor Hyam Leffert

Section: Hepatology

Professor Leffert

Department of Pharmacology, School of Medicine, University of California at San Diego, La Jolla, CA, USA

Professor Leffert attended the University of Rochester, Rochester, NY (B.A., Intellectual History, 1965), where he studied Necturus blood cells with Professor Ernst Caspari; Brandeis University, Waltham, Mass (M.A., Biology, 1967), where he reconstituted a primary immune response in vitro with Professor Gordon Sato; and the Albert Einstein College of Medicine, Bronx, NY (M.D.,1971), where he discovered a lecithinase-producing Bacillus cereus in a newborn suffering from Meningitis and bacteremia after ventriculoatrial shunt-revision (he identified the organism by its GC-base composition with Professor Julius Marmur). His internship at UCSD (La Jolla, CA, 1972) was split between Pediatrics, and Biology, where he developed selection methods to culture proliferation- and differentiation-competent primary hepatocytes for use as model systems of liver development and regeneration.

Dr. Leffert continued basic research at the Salk Institute, where, as an NCI/NIH/Damon Runyon Cancer Research Fellow and an Assistant Professor of Cell Biology, he directed liver growth control studies alongside many students, postdocs, and sabbatical visitors through 1980. Several growth factors were discovered (insulin, glucagon and epidermal growth factor; thereafter, insulin-like growth-factors IGF-I and IGF-II and TGF-α). Later studies provided molecular understanding of relationships between growth factors, regeneration and the expression and biochemistry of cyclins D1, B, A and E. Drs. Koch and Leffert, and Stewart Sell, UCSD Professor of Pathology, also observed expression of α-fetoprotein, a clinical marker of human hepatocellular carcinoma, in neonatal hepatocytes undergoing liver development in vitro and in vivo, and in normal long-term primary hepatocyte cultures simulating liver regeneration. Further work revealed that primary hepatocytes enzymatically converted chemical procarcinogens like N-Acetyl-2-Aminofluorene (AAF) into carcinogenic metabolites -- research that enabled precision drug metabolism studies by the pharmaceutical industry. In 1987, with Professor Ted Friedmann (UCSD Pediatrics), Dr. Leffert introduced genes into hepatocytes using retroviral vectors (initiating hepatic gene therapy research). Dr. Leffert was awarded a John Simon Guggenheim Memorial Fellowship, and a Morton Grossman Research Scholar Award by the American Gastroenterological Association, to study Molecular Cancer Genetics with Sir Henry Harris at the Sir William Dunn School of Pathology at Oxford University.

Currently, Drs. Leffert, Koch and Sell, are focused upon determination of pharmacokinetic growth cycle-dependent metabolic and covalent binding parameters of AAF, and the implication these new findings have with respect to translesion hepatocyte DNA synthesis and the chemical induction of hepatocellular carcinoma.

Prof. Dr. Héctor Mora-Montes

Section: Infectious Diseases

Prof. Dr. Mora-Montes

Department of Biology, Division of Natural and Exact Sciences, University of Guanajuato, Guanajuato, Mexico

During his post as a clinical analyst, Prof. Mora-Montes developed a system for the differentiation of Candida species, based on in-house zymograms and colony morphology in cornmeal agar. As a postgraduate student, he generated a new and innovative method for in situ determination of glycosyl hydrolase activities and received the “Summa Cum Laude” distinction from Universidad de Guanajuato. Among the most important achievements during his time as a postdoctoral fellow at the University of Aberdeen (Scotland), he set up most of the immunological techniques within the Aberdeen Fungal Group and developed and standardized protocols for the isolation and purification of chitin, phospholipomannan, N-linked and O-linked mannans from fungal cells. Those protocols have not only benefited the Aberdeen Fungal Group, but other international groups dedicated to the study of the fungal cell wall, and are considered among the most popular and standardized methods for isolation and analysis of fungal cell wall components.

In 2010, he established the Laboratory of Fungal Glycobiology at Universidad de Guanajuato (Mexico), with the main goal to understand the mechanisms behind the fungal cell wall synthesis and the interaction of medically relevant fungal pathogens with the host. This laboratory is characterized by its facilities to perform chemical, immunological, genetic, molecular and cellular analyses of human fungal pathogens. Therefore, it is among a handful of research facilities within Mexico and Latin America offering a multidisciplinary and integral approach to understand these pathogens. Currently, the group is developing molecular tools for genetic manipulation of medically relevant fungi, in particular Sporothrix and Candida species. Our group has a solid international reputation in the genetic study of these organisms, in the immune sensing of fungal cells, and the development of alternative models to analyze fungal virulence.

Since 2016, he was awarded the level III distinction by SNI, the highest distinction awarded by the Mexican Government for Mexican Researchers under 65 years old. He currently holds editorial appointments in several peer-reviewed international journals and is the Deputy President of the Latin-American Society of Glycobiology.

Dr Franco Musio

Section: Nephrology

Dr Musio

Associate Professor of Medicine, University of Virginia School of Medicine, Charlottesville, VA, USA

Dr. Franco Musio has been very active in multiple realms of the medical profession: clinical and academic medicine, administrative responsibilities, and humanitarian work. Dr. Musio attended Georgetown University undergraduate and medical school followed by a Transitional Internship at Walter Reed Army Medical Center (WRAMC), a two year post Internship Army Group Surgeon position at Hellenikon Air Force Base Hospital (Athens, Greece), residencies in General Surgery and Internal Medicine at Brooke Army Medical Center (San Antonio, TX), and nephrology fellowship at WRAMC where he remained on staff with multiple clinical roles. Dr. Musio was in private practice from 1998 until 2022 during which time he wore many 'hats' in medical leadership and directorship roles.

Currently, Dr. Musio is avidly involved in many ongoing projects to include local and national radio broadcasts involving medical and human-interest topics, expert opinion work in the fields of nephrology and internal medicine, medical assignments in treating patients in multiple referral hospitals throughout the United States.

Dr. Musio has a passion for teaching medical students, residents, fellows, and physicians at all levels since 1994 in the capacity of his academic appointments at various medical schools to include Uniformed Services University of the Health Sciences, Virginia Commonwealth University School of Medicine (Inova Fairfax Campus), and currently the University of Virginia School of Medicine (Inova Fairfax Campus). He enjoys writing, mentoring, academic teaching projects, national and international lecturing, and reviewing/editing medical articles from over twenty medical journals.

Professor Satish Chandrasekhar Nair

Section: Public Health

Professor Nair

College of Medicine, Tawam Hospital, UAE University, Al Ain, United Arab Emirates

Professor Satish Chandrasekhar Nair has the unique distinction of serving at senior positions in the pharmaceutical industry and, at academic medical centers in the USA, India and the United Arab Emirates, for over 25 years. He obtained his PhD (faculty of medicine) following graduation from the TN Medical College. In addition, he is American Board certified in medical quality, and informatics. He further obtained MBA in healthcare management from the University of Nebraska. He has proven expertise in clinical trials, designing clinical trails, research ethics, medical ethics, joint commission hospital accreditation, patient safety, medical quality and public health.

He has over 100 international peer reviewed PubMed indexed publications. His publications include Lancet, Breast Cancer, International Journal Public health and other reputed publications. He serves on the editorial board of several international journals, and was awarded several global awards such as the Technology Pioneer, Marcus Evans best speaker, and innovative professional awards from the USA, Switzerland, Japan and the UAE. He has authored several COVID-19 publications recently. He is currently the associate professor, college of medicine, UAE University, and the Director for clinical research at Tawam Hospital, Al Ain, UAE. He is involved in medical residency research training.

Dr Redoy Ranjan

Section: Cardiology AND Clinical Neurology

Dr Ranjan

Department of Cardiac Surgery, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh; Stroke Scientist, Royal Holloway University Of London, London, UK

Dr. Redoy Ranjan is a consultant cardiac surgeon at Bangabandhu Sheikh Mujib Medical University (BSMMU) in Bangladesh. He is currently pursuing a PhD in cerebral venous thrombosis at the Royal Holloway University of London (RHUL) in the United Kingdom. Dr. Ranjan has been a member of the Royal College of Surgeons of Edinburgh since 2016 and a Fellow of the American College of Surgeons since 2020. He graduated with an MBBS in 2009 and was awarded a postgraduate MS in cardiovascular and thoracic surgery in 2017. He trained as a Cardiovascular and Thoracic surgeon at the Bangabandhu Sheikh Mujib Medical University, Bangladesh. Later, he pursued a second master's degree in vascular and endovascular surgery at the University of Edinburgh, UK, where he graduated with Distinction in 2020.

At RHUL, he works as a research fellow, initially looking into risk factors for cerebral venous thrombosis (CVT) and later at the genetics of hereditary thrombophilia associated with CVT. His primary clinical interest is in surgical myocardial revascularisation, specifically total arterial CABG, minimally invasive CABG, and coronary endarterectomy. He is also interested in stroke, particularly cerebral venous thrombosis and atrial fibrillation (AF). His research focuses on the risk factors associated with persistent AF and the long-term outcomes of convergent ablation with left atrial appendage exclusion.

Dr. Ranjan has been honoured with the Bangladesh University Grant Commission Gold Medal and has also received the prestigious "Bangabandhu Science and Technology Fellowship" to pursue his PhD at the RHUL, UK. He is an academic editor and serves on the editorial board of various scientific journals. Dr. Ranjan has published numerous outstanding peer-reviewed articles on adult cardiac surgery and cerebral venous thrombosis.

Prof. Dr. Leonardo Oliveira Reis

Section: Oncology AND Urology

Prof. Dr. Reis

UroScience, School of Medicine, Pontifical Catholic University of Campinas and University of Campinas, Campinas, São Paulo, Brazil

Leonardo Oliveira Reis is Professor of Urology and Uro-Oncology at the State University of Campinas, Unicamp and the Pontifical Catholic University of Campinas, PUC-Campinas, Fulbright Visiting Professor at Harvard University, Urology Fellow at Columbia University, New York, NY, USA (American Urological Association, 2011). Postdoctoral Fellow at The Johns Hopkins University, School of Medicine, Baltimore, MD, USA (CAPES, 2014-2015). Research Productivity 1 of the Brazilian National Council for Scientific and Technological Development, CNPq, aimed at researchers who stand out among their peers according to normative criteria. Has experience in Urology, with emphasis on Urological Oncology. He is the author/co-author of >200 scientific articles indexed by PUBMED, >40 Chapters of National and International Books, Top Reviewer @Publons, CAPES Theses Award 2012 Medicina III (Surgery). National and International Ad hoc advisor. Executive Member of the World Urologic Oncology Federation (WUOF). AUA International Member and Scholar. Handling Editor for the World Journal of Urology (Springer), ex-official journal of the Société Internationale d'Urologie (SIU), and Associate and Section Editor, International Brazilian Journal of Urology (IBJU), the official journal of the Brazilian Society of Urology (SBU), and the American Confederation of Urology (CAU). Scientific Director (2018-19) of the Brazilian Society of Urology (SBU), São Paulo Section. President of the Human Ethics Committee for Research (2016-2019) of the Pontifical Catholic University of Campinas, PUC-Campinas. Latin America Top Scientist (AD Scientific Index 2021, 2022). 

Dr Hossam El-Din Shaaban

Section: Gastroenterology AND Hepatology

Dr Shaaban

Gastroenterology and Endoscopy consultant, North Cumbria Integrated Care NHS Foundation Trust, Carlisle, UK

Dr. Hossam El-Din Shaaban is currently a gastroenterology and endoscopy consultant at North Cumbria Integrated Care NHS Foundation Trust. Graduating from Cairo University Faculty of Medicine in 2001, he got his Masters Degree in Internal Medicine in 2009, and then his Medical Doctorate in Internal Medicine in 2018 both from Cairo University. He is a fellow of the American College of Gastroenterology (ACG) and the American Society of Gastrointestinal Endoscopy (ASGE).

Dr. Shaaban has authored 40 peer reviewed journal publications. He serves as a peer reviewer for multiple journals. His current H-index is 7 in Google Scholar, and 6 in Scopus and Clarivate Web of Science. 

Prof. Dr. Yuriy Sirenko

Section: Cardiology

Prof. Dr. Sirenko

Department of Arterial Hypertensions, National Scientific Center, National Academy of Medical Science, Kyiv, Ukraine

Professor Yuriy Sirenko is Head of Department of Arterial Hypertensions in the National Scientific Center "M.D. Strazhesko Institute of Cardiology, Clinical and Regenerative Medicine" of the National Academy of Medical Science. His research interests include primary and secondary arterial hypertension, cardio-vascular prevention, pulmonary arterial hypertension, heart failure, right heart catheterization, hemodynamic changes, role of RAS, coronary artery disease, drug and non-drug therapy, emergency and intensive care in cardiology, and coronary artery disease. He has completed more than 600 publications in the fields of cardiology and hypertension.

Professor David E. Stec

Section: Hematology AND Nephrology

Professor Stec

Department of Physiology & Biophysics, University of Mississippi Medical Center, Jackson, MS, USA

Dr. David E. Stec is a Professor of Physiology and Biophysics at the University of Mississippi Medical Center in Jackson, Mississippi, USA. He is also the director of the Cardiovascular-Renal Research Center.

Dr. Stec's research focuses on the mechanisms by which metabolic diseases result in the development of cardiovascular and renal disease. His lab has also discovered novel signaling properties of bilirubin and developed the first conditional knockouts of biliverdin reductase to study its role in the development of non-alcoholic fatty liver disease and it role in the regulation of blood pressure.

Dr. Stec has received research awards locally, nationally, and internationally for his research. His research has been funded by the National Institutes of Health and the American Heart Association.

Dr Dinesh Vyas

Section: Oncology

Dr Vyas

Department of Surgery, California Northstate University College of Medicine, Elk Grove, CA, USA

Dr. Vyas is a distinguished internationally acclaimed surgeon, and researcher, academic leader, business executive, mass media exploit educator, global health pioneer in prehospital care pedagogy, and a trailblazer in the space of medical device innovation. With an extensive experience and successful career as Associate Dean of Surgery Research, CEO, CMO, Chair of University and Community Surgery Department, Program Director Surgery Residency, and Innovation, Research & Quality Head, Dr. Vyas has mentored many academic physicians. He is among the top ten advanced robotic gastrointestinal surgeons in Northern California, performing a high volume of cases with exceptional outcomes.

An advisor to multiple funds & startups, while promoting innovation thru his incubator with four startups. In addition, pioneer of MOOC in the medical space. Dr. Vyas is an avid learner and surrounds himself with more knowledgeable people, and exemplifies the fortitude of thriving in uncharted terrains. His scientific work is known for several medical firsts and published in the prestigious journals like iScience. First Surgeon of Southeast Asian training to have a contributed as both Surgery Program Director, and University Surgery Department Chair, enriching the US education system. NPR, Gulf Times published his work and keynote speaker at FT healthcare and Beckers CEO and other prestigious conferences.
Dr. Vyas has made surgical, basic science (nanotechnology) and clinical contributions and improved care like substantially decreasing complications of gangrenous gallbladder surgery (35% to 5%); esophageal perforation, a largest series on underwater colonoscopy for increasing trained endoscopists; the largest robotic surgery series on gastric volvulus with hiatal hernia, and more.

Dr. Vyas' eclectic list of major accomplishments includes over 100 peer reviewed publications (h-index 21) and abstracts, 200 invited talks, Editor-In-Chief of two textbooks, Editor-In-Chief of three journals, founder of multiple trauma training centers, and more than fifteen patents published or in the process. Dr. Vyas' incubator has several success stories, and he has a few medical devices ready for prime time. StaplCam is the world's first fully disposable operating room system nearly ready for FDA clearance. SMORTS, a disruption in injury prediction using AI/ML in a smart garment enhancing warehouse industry and sports personnel. Dr. Vyas' philosophy is: "Efforts must be designed to have an impact."
Training: University of Pittsburgh, Case Western Reserve University, and Rajasthan University.

Dr Sandul Yasobant

Section: Infectious Diseases AND Public Health

Dr Yasobant

Centre for One Health, Education, Research & Development (COHERD), Indian Institute of Public Health Gandhinagar, Gujarat, India

Sandul Yasobant is working as a Technical Officer (Research) at the Indian Institute of Public Health Gandhinagar (IIPHG), India; a Postdoc fellow at the Institute for Hygiene & Public Health, University Hospital Bonn, Germany; an Associate Researcher at the Center for Development Research (ZEF), University of Bonn, Germany; an Adjunct Faculty at the Datta Meghe Institute of Medical Sciences (DMIMS), India. He also holds editorial affiliations with Springer Nature, Frontiers, PLOS, and Taylor & Francis.

Originally from Odisha (eastern India), Dr. Yasobant has completed his health education and public health training at Utkal University, Sri Ramachandra University in India, and the University of Bonn in Germany. He has completed the Doctoral Program 'One Health & UrbanTransformation' at ZEF and obtained a public health doctoral degree from the medical faculty, University of Bonn, Germany, in 2020.

Dr. Yasobant's research incorporates health policy and system research, One Health and disease prevention, and environment and occupational health. Dr. Yasobant has conducted extensive research in Southeast Asia and is currently engaged in research activities in India and Ghana. He has published more than 50 peer-reviewed international journal articles and three book chapters and edited one volume of a book.

Dr Xudong Zhu

Section: Endocrinology AND Gastroenterology

Dr Zhu

Markey Cancer Center, University of Kentucky, Lexington, KY, USA

Dr. Xudong Zhu obtained his BMed, M.D., and Ph.D. from China Medical University (Shenyang, China). Now, he is an Assistant Professor at the Cancer Hospital of Dalian University of Technology and a Post-doctoral Scholar at Markey Cancer Center of University of Kentucky. 

His research is mainly focused on the pathogenesis of endocrinology-related diseases including endocrinology-related cancer, especially breast cancer, and gastroenterology-related disease including hepatocellular carcinoma, gastric carcinoma and others. He is also focused on screening and validating small molecular compounds which could effectively target and kill endocrinology-related and gastroenterology-related solid cancer cells.

Dr. Zhu has published more than 20 articles in peer-reviewed journals with a total impact factor of nearly 200. He is a regular peer reviewer for manuscripts submitted to SCI journals and is a member of the Editorial Board of 7 English journals.

Editorial Board

Dr Priyanka Bhugra, Clinical Medicine, Houston Methodist Hospital/ Weill Cornell Medical College, Houston, TX, USA

Dr Charlie Bridgewood, Leeds Institute of Rheumatic & Musculoskeletal Medicine, University of Leeds, Leeds, UK

Dr Kevin Chamberlin, Pharmacy, UConn School of Pharmacy, Storrs, CT, USA

Prof. Dr. Gopal Krishna Dhali, Gastroenterology, School of Digestive and Liver Diseases, Institute of Postgraduate Medical Education and Research, Kolkata, West Bengal, India

Dr Mengyuan Ding, Brigham and Women’s Hospital, Harvard Medical School, Boston, MA, USA

Professor Perenlei Enkhbaatar, Department of Anesthesiology, University of Texas Medical Branch, Galveston, TX, USA

Professor Asghar Fazaeli, Department of Medical Parasitology and Mycology, Zanjan University of Medical Sciences, Zanjan Province, Zanjan, Iran

Professor Levent Filik, Gastroenterology Department, Ankara Research Hospital, Ankara, Turkey

Dr Domenico Giannese, Nephrology Department, Pisa University Hospital, Pisa, Italy

Dr Anju Gupta, Anaesthesiology, Pain Medicine and Critical Care, All India Institute of Medical Sciences, Delhi, India

Professor Anut Itthagarun, Department of Pediatric Dentistry, Griffith University, QLD, Australia

Professor Robert Kaplan, Clinical Excellence Research Center, Stanford University, Stanford, CA, USA

Post-Doctoral Fellow, Erum Khan, Department of Neurology, The University of Alabama at Birmingham, Birmingham, AL, USA

Prof. Dr. Shinichi Mitsui, Department of Rehabilitation Sciences, Gunma University Graduate School of Health Sciences, Maebashi, Gunma, Japan

Professor Franz Oesch, Institute of Toxicology, University of Mainz, Mainz, Germany

Dr Russell Phillips, Center for Primary Care, Harvard Medical School, Boston, MA, USA

Dr Amit Ray, Neurology, Aurora Healthcare, Milwaukee, Wisconsin, USA

Dr Kamal Kant Sahu, Division of Hematology and Medical Oncology, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA

Dr Taro Shimizu, Department of Diagnostic and Generalist Medicine, Dokkyo Medical University, Shimotsuga, Tochigi, Japan

Dr Vasileios Zochios, Department of Critical Care Medicine, University Hospitals Birmingham NHS Foundation Trust, Queen Elizabeth Hospital Birmingham, Birmingham, UK